Fatal Hemorrhagic Shock: The Superiority of Compatible Fresh Frozen Plasma as a Resuscitation Agent.

Abstract

We developed a fixed-volume porcine hemorrhage model that simulates the rapid exsanguination of combat or civilian trauma victims. In this study we compared the ability of five resuscitation solutions to prevent death after an otherwise lethal hemorrhage in 100 swine. The shed blood was replace in a 1:1 with either autologous whole blood (WB), untyped swine-fresh frozen plasma (FFP), type FFP, 5 percent human serum albumin (ALB), or normal saline (NS). survival rate analysis indicated that WB was significantly better than FFP (untyped), ALB or NS but not better than typed FFP. The 24-hour survival rates were: WB = 90%, typed FFP = 79%, untyped FFP = 56%, ALB = 57%, and NS = 25%. All deaths in the untyped FFP group suddenly occurred during or with in 15 minutes after treatment in a recovering animal. Deaths in the ALB group steadily occurred for up to 150 minutes after treatment. Analysis of hemodynamic, arterial blood gas, and acid-base data indicated that WB and FFP provided a better acid buffering capacity in surviving animals than NS or ALB. We conclude that compatible FFP is a better resuscitation agent than ALB after an otherwise fatal hemorrhage because FFP is a better acid buffer. (Author)

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Aug 01, 1984
Accession Number
ADA147267

Entities

People

  • L. R. Deguzman
  • L. W. Traverso
  • M. J. Langford
  • R. B. Bolin
  • S. J. Hollenbach

Organizations

  • Letterman Army Hospital

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Acid-Base Imbalance
  • Albumins
  • Biological Sciences
  • Blood
  • Cardiovascular System
  • Combat Injuries
  • Health Services
  • Hemorrhage
  • Hemorrhagic Shock
  • Materials
  • Military Research
  • Nervous System
  • Plastic Explosives
  • Respiration Disorders
  • Surgery
  • Tissues
  • Warfare

Fields of Study

  • Medicine

Readers

  • Aviation Safety Risk Assessment.
  • Cardiovascular Physiology
  • Surface Coatings Technology.